Sign In

October 22, 2014
New, significantly improved hepatitis C drugs have revolutionized how the disease is treated, but they are also expensive.
October 22, 2014
Two new pill-only regimens that rapidly cure most patients with genotype 1 hepatitis C (HCV) infection could soon be widely prescribed across Europe.
October 20, 2014
Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently.
October 17, 2014
The liver provides critical functions, such as ridding the body of toxins. Its failure can be deadly, and there are few options for fixing it.
October 16, 2014
Immune cells that migrate to the liver and interact there with liver tissue cells get activated by metabolic stress (e.g.
October 15, 2014
Isansys Lifecare Ltd, the provider of complete real-time physiological patient data services and systems, announces the results of a pilot collaborative study, with UCL Hepatology and supported by...
October 14, 2014
The U.S. Food and Drug Administration has approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.
October 14, 2014
A new study claims that obesity speeds up aging of the liver, potentially explaining why some obese individuals experience early onset age-related diseases, such as liver cancer.
October 13, 2014
Excessive and often lethal blood levels of bilirubin can result from mutations in a single gene that are the cause of the metabolic disease known as Crigler-Najjar syndrome type 1 (CNS1).
October 13, 2014

Press 

Pages